Addtech AB
LSE:0QI7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Addtech AB
LSE:0QI7
|
SE |
|
Immunitybio Inc
NASDAQ:IBRX
|
US |
|
L
|
L'Occitane International SA
XBER:COC
|
LU |
|
Raffles Medical Group Ltd
F:02M1
|
SG |
|
Midea Real Estate Holding Ltd
F:MR9
|
CN |
|
Venus Concept Inc
NASDAQ:VERO
|
CA |
|
V
|
Victory Square Technologies Inc
SWB:6F6
|
CA |
|
P
|
Pelican Acquisition Corp
NASDAQ:PELI
|
US |
|
Sun Country Airlines Holdings Inc
F:6X2
|
US |
|
Develop Global Ltd
F:IHB1
|
AU |
|
Critical Elements Lithium Corp
OTC:CRECF
|
CA |
|
L E Lundbergforetagen AB (publ)
F:LU3B
|
SE |
|
U
|
Ucore Rare Metals Inc
XBER:U9UA
|
CA |
|
London Stock Exchange Group PLC
F:LS4D
|
UK |
|
A
|
Anand Rathi Wealth Ltd
NSE:ANANDRATHI
|
IN |
|
Arkema SA
PAR:AKE
|
FR |
Wall St Price Targets
0QI7 Price Targets Summary
Addtech AB
According to Wall Street analysts, the average 1-year price target for 0QI7 is 382.55 SEK with a low forecast of 334.23 SEK and a high forecast of 423.28 SEK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QI7's stock price target?
Price Target
382.55
SEK
According to Wall Street analysts, the average 1-year price target for 0QI7 is 382.55 SEK with a low forecast of 334.23 SEK and a high forecast of 423.28 SEK.
What is the Revenue forecast for Addtech AB?
Projected CAGR
6%
Over the last 8 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 4 years is 6%.
What is the Operating Income forecast for Addtech AB?
Projected CAGR
11%
Over the last 8 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 4 years is 11%.
What is the Net Income forecast for Addtech AB?
Projected CAGR
13%
Over the last 8 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 4 years is 13%.
